HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tobias Jäger Selected Research

TC 81

2/2006The GNAS1 T393C polymorphism predicts survival in patients with clear cell renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tobias Jäger Research Topics

Disease

6Urinary Bladder Neoplasms (Bladder Cancer)
09/2012 - 12/2008
5Neoplasms (Cancer)
09/2012 - 02/2006
3Neoplasm Metastasis (Metastasis)
09/2012 - 02/2006
2Disease Progression
06/2011 - 02/2006
1Carcinoma (Carcinomatosis)
09/2012
1Pathologic Neovascularization
12/2008
1Carcinoma in Situ
10/2007
1Seminoma
10/2007
1Renal Cell Carcinoma (Grawitz Tumor)
02/2006

Drug/Important Bio-Agent (IBA)

3ImmunosorbentsIBA
09/2012 - 06/2009
3EnzymesIBA
09/2012 - 06/2009
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2009 - 12/2008
1AngiostatinsIBA
09/2012
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
09/2012
1Tyrosine (L-Tyrosine)FDA Link
09/2012
1Phosphotransferases (Kinase)IBA
09/2012
1Matrix Metalloproteinase 7 (Matrilysin)IBA
04/2011
1Matrix Metalloproteinases (MMPs)IBA
04/2011
1Cadherins (E-Cadherin)IBA
04/2010
1TIE-2 Receptor (Receptor, TIE 2)IBA
12/2008
1AngiopoietinsIBA
12/2008
1Inhibitor of Apoptosis ProteinsIBA
10/2007
1Messenger RNA (mRNA)IBA
10/2007
1Tumor Biomarkers (Tumor Markers)IBA
02/2006
1Proteins (Proteins, Gene)FDA Link
02/2006
1TC 81IBA
02/2006

Therapy/Procedure

1Adjuvant Chemotherapy
06/2011
1Lymph Node Excision (Lymph Node Dissection)
06/2011
1Therapeutics
04/2011
1Nephrectomy
02/2006